Alpha Cubed Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $412K | Sell |
16,556
-1,164
| -7% | -$29.4K | 0.01% | 200 |
|
|
2025
Q3 | $452K | Sell |
17,720
-5,820
| -25% | -$144K | 0.02% | 190 |
|
|
2025
Q2 | $571K | Buy |
23,540
+527
| +2% | +$12.3K | 0.02% | 169 |
|
|
2025
Q1 | $583K | Sell |
23,013
-2,681
| -10% | -$70.2K | 0.03% | 156 |
|
|
2024
Q4 | $682K | Sell |
25,694
-2,849
| -10% | -$77.3K | 0.03% | 134 |
|
|
2024
Q3 | $826K | Sell |
28,543
-1,734
| -6% | -$50.6K | 0.04% | 117 |
|
|
2024
Q2 | $847K | Sell |
30,277
-1,572
| -5% | -$43.3K | 0.04% | 120 |
|
|
2024
Q1 | $884K | Sell |
31,849
-2,897
| -8% | -$80.4K | 0.05% | 117 |
|
|
2023
Q4 | $1M | Buy |
34,746
+608
| +2% | +$18.4K | 0.06% | 119 |
|
|
2023
Q3 | $1.13M | Sell |
34,138
-16,964
| -33% | -$600K | 0.08% | 98 |
|
|
2023
Q2 | $1.87M | Sell |
51,102
-269,902
| -84% | -$10.5M | 0.13% | 85 |
|
|
2023
Q1 | $13.1M | Sell |
321,004
-13,109
| -4% | -$566K | 0.95% | 36 |
|
|
2022
Q4 | $17.1M | Sell |
334,113
-69,056
| -17% | -$3.31M | 1.3% | 28 |
|
|
2022
Q3 | $17.6M | Sell |
403,169
-18,073
| -4% | -$878K | 1.38% | 24 |
|
|
2022
Q2 | $22.1M | Buy |
421,242
+15,343
| +4% | +$782K | 1.6% | 21 |
|
|
2022
Q1 | $21M | Sell |
405,899
-3,236
| -0.8% | -$168K | 1.35% | 26 |
|
|
2021
Q4 | $24.2M | Buy |
409,135
+7,279
| +2% | +$361K | 1.58% | 20 |
|
|
2021
Q3 | $17.3M | Buy |
401,856
+2,519
| +0.6% | +$112K | 1.3% | 25 |
|
|
2021
Q2 | $15.6M | Buy |
399,337
+33,071
| +9% | +$1.29M | 1.13% | 29 |
|
|
2021
Q1 | $13.3M | Buy |
366,266
+18,546
| +5% | +$658K | 1.03% | 29 |
|
|
2020
Q4 | $12.8M | Buy |
347,720
+86,953
| +33% | +$3.19M | 1.09% | 28 |
|
|
2020
Q3 | $9.08M | Buy |
260,767
+100,189
| +62% | +$3.51M | 0.87% | 39 |
|
|
2020
Q2 | $4.98M | Sell |
160,578
-3,371
| -2% | -$115K | 0.55% | 52 |
|
|
2020
Q1 | $5.08M | Buy |
163,949
+135,669
| +480% | +$4.62M | 0.61% | 49 |
|
|
2019
Q4 | $1.05M | Sell |
28,280
-1,722
| -6% | -$61.3K | 0.11% | 101 |
|
|
2019
Q3 | $1.02M | Sell |
30,002
-1,498
| -5% | -$54.5K | 0.12% | 93 |
|
|
2019
Q2 | $1.29M | Buy |
31,500
+4,201
| +15% | +$167K | 0.15% | 90 |
|
|
2019
Q1 | $1.1M | Buy |
27,299
+4,881
| +22% | +$195K | 0.13% | 91 |
|
|
2018
Q4 | $928K | Sell |
22,418
-13,646
| -38% | -$566K | 0.14% | 89 |
|
|
2018
Q3 | $1.52M | Buy |
36,064
+15,483
| +75% | +$596K | 0.18% | 93 |
|
|
2018
Q2 | $708K | Sell |
20,581
-3,591
| -15% | -$123K | 0.09% | 100 |
|
|
2018
Q1 | $814K | Sell |
24,172
-4,573
| -16% | -$157K | 0.11% | 97 |
|
|
2017
Q4 | $988K | Sell |
28,745
-3,714
| -11% | -$127K | 0.13% | 94 |
|
|
2017
Q3 | $1.1M | Sell |
32,459
-261
| -0.8% | -$8.39K | 0.17% | 86 |
|
|
2017
Q2 | $1.04M | Sell |
32,720
-11,533
| -26% | -$364K | 0.18% | 77 |
|
|
2017
Q1 | $1.44M | Sell |
44,253
-9,623
| -18% | -$303K | 0.29% | 56 |
|
|
2016
Q4 | $1.66M | Buy |
53,876
+7,538
| +16% | +$230K | 0.4% | 51 |
|
|
2016
Q3 | $1.49M | Buy |
46,338
+20,822
| +82% | +$696K | 0.4% | 50 |
|
|
2016
Q2 | $852K | Sell |
25,516
-15,181
| -37% | -$485K | 0.29% | 58 |
|
|
2016
Q1 | $1.14M | Buy |
40,697
+3,499
| +9% | +$99.9K | 0.35% | 57 |
|
|
2015
Q4 | $1.14M | Buy |
37,198
+1,599
| +4% | +$50.3K | 0.3% | 71 |
|
|
2015
Q3 | $1.14M | Buy |
35,599
+3,197
| +10% | +$103K | 0.3% | 73 |
|
|
2015
Q2 | $1.03M | Buy |
32,402
+11,755
| +57% | +$383K | 0.28% | 88 |
|
|
2015
Q1 | $682K | Buy |
20,647
+6,007
| +41% | +$191K | 0.21% | 101 |
|
|
2014
Q4 | $433K | Sell |
14,640
-742
| -5% | -$21.3K | 0.17% | 101 |
|
|
2014
Q3 | $432K | Sell |
15,382
-3,375
| -18% | -$94.7K | 0.2% | 104 |
|
|
2014
Q2 | $528K | Sell |
18,757
-1,046
| -5% | -$29.8K | 0.24% | 112 |
|
|
2014
Q1 | $604K | Sell |
19,803
-43,322
| -69% | -$1.29M | 0.31% | 99 |
|
|
2013
Q4 | $1.83M | Buy |
+63,125
| New | +$1.84M | 0.66% | 54 |
|
Other funds holding PFE
Alpha Cubed Investments's PFE Position: Q4 2025 in Review
Alpha Cubed Investments reduced its Pfizer (PFE) stake by 6.6% in Q4 2025, selling an estimated $29.4K and leaving 16,556 shares worth $412K. The position accounts for 0.01% of the portfolio, ranked #200.
Alpha Cubed Investments first reported a position in PFE in Q4 2013 and has held it in 49 quarters since. The position peaked at $24.2M in Q4 2021. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Alpha Cubed Investments held 16,556 shares of Pfizer worth $412K as of Q4 2025.
- Alpha Cubed Investments sold 1,164 Pfizer shares in Q4 2025, an estimated $29.4K.
- Pfizer made up 0.01% of Alpha Cubed Investments's portfolio in Q4 2025, its #200 holding.
- Alpha Cubed Investments first reported a position in Pfizer in Q4 2013 and has held it in 49 quarters since.
- Alpha Cubed Investments's Pfizer position peaked at $24.2M in Q4 2021.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Alpha Cubed Investments's 13F filing for Q4 2025, filed 3 Feb 2026.